Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

RoosterBio Blog

Adipose & Bone Marrow-Derived hMSCs: What’s the Difference?

April 22, 2015 MSCs & Characterization

INTRODUCTION Human Mesenchymal Stem/Stromal Cells, or hMSC, are key components of future therapeutics, engineered tissues, and medical devices and are currently in use in over 400 clinical trials (1). Bone ... More

NIST Workshop Aims to Educate on Improving Confidence in Measurements Critical for Cell Therapy Products

April 13, 2015 Conference Highlights

We are always looking for ways to enable the commercialization of Cell-based Therapy and Technology.  The ultimate success of the field is dependent on the convergence of several technology fields, ... More

Sidebar Navigation

  • BioEconomy
  • Biomanufacturing
  • Bioprinting & Biofabrication
  • Bioprocessing
  • Cell Therapy
  • Conference Highlights
  • Corporate
  • COVID-19
  • Exosomes / Extracellular Vesicles
  • Genetic Engineering
  • MSCs & Characterization
  • Quality & Regulatory
  • Tissue Engineering
#1 Most Popular Blogs 3D Culture Adipose MSCs Adult Stem Cells Advanced Therapies Analytics BioEconomy Biomanufacturing Biomaterials Bioprinting / Biofabrication Bioprocess Bioreactors Bone Marrow MSCs Cell Therapy Clinical Trials COVID-19 Democratizing Technology Exosomes / Extracellular Vesicles Fetal Bovine Serum Genetic Engineering GMP Manufacturing Mesenchymal Stem / Stromal Cells Regenerative Medicine Regulatory RoosterBio Standardization Tissue Engineering Umbilical Cord MSCs

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email